Furthermore, sputum total IgE may also serve as a potential biomarker for guiding anti‐IL‐5 therapy in patients with severe asthma, with higher levels of sputum total IgE possibly predicting better responses to anti‐IL‐5 therapy.43 This evidence concerns the gene IGHE and asthma.